EPO and vitamin D deficiency: Early identification of patients with increased risk of developing EPO resistance, promptly administration of appropriate therapy, and individualization of dialysis prescription may provide the opportunity for optimal control of OS, microinflammation, malnutrition, vitamin D deficiency, and iron status.